Unconjugated Free Estriol Saliva Sensitive ELISA
The Unconjugated Free Estriol Saliva Sensitive ELISA is For Research Use Only
Size: 1×96 wells
Sensitivity: 0.860 pg/ml
Incubation Time: 2 hours
Sample Type: Human Saliva
Sample Size: 50 µl
Product manufactured in the USA
Storage and Stability
When stored at 2° – 8°C, unopened reagents will retain activity until the expiration date. Do not use reagents beyond this date.
Use only reagents supplied with this kit. Do not interchange reagents with different lot numbers.
Opened reagents must be stored at 2° – 8°C.
Microtiter wells must be stored at 2° – 8°C. Once the foil bag has been opened, care should be taken to reseal tightly.
Opened kits retain activity for 28 days if stored as described above.
Expiration dates and lot numbers are printed on the labels.
Estriol is the weakest of the three major estrogens with a binding affinity for the estrogen receptor about 1/100 that of estradiol. Physiologically significant amounts of Estriol are only present during pregnancy or with supplementation. Estriol is available, mainly, as a custom compounded product and is one of the components of bi- or tri-estrogen creams usually in a ratio of estradiol to estrone to estriol 1:1:8. Salivary estriol median levels are <2 pg/ml in non-pregnant pre- and post-menopausal women as well as in men. These levels represent little to no physiologic estrogenic activity. In pregnancy, low levels of Estriol may indicate fetal distress and in Down Syndrome Estriol measurements are part of a screen for this condition.
- Canez, MS, LEE, KH, Olive, DL, Progestogens and Estrogens, Infertil Reproduct Med Clin No Amer 1992, 3: 59-78.
- Yang, TS, Tsan, SH, Chang, SP, Ng, HT, Efficacy and Safety of Estriol Replacement Therapy for Climacteric Women, Chung Hua I Hsueh Tsa Chich (Taipei), 1995, 550 (5): 386-91.
- McGregor, JA, Jackson, GM, Lachelin, GCl, et al., Salivary Estriol as Risk Assessment for Preterm Labor: A Prospective Trial, Am J Obstet Gynecol 1995, 173:4, 1337-1342.
- Reis, F.M., D’Antona, D., and Petraglis, F. (2002). Predictive Values of Hormone Measurements in Maternal and Fetal Complications of Pregnancy. Endocrine Reviews, 23 (2) 230-257.